NTP peer review
This article was originally published in The Rose Sheet
Executive Summary
The National Toxicology Program Board of Scientific Counselors Technical Reports Review Subcommittee will meet Aug. 28 to discuss peer review findings and conclusions presented in five draft NTP technical reports of rodent toxicology and carcinogenicity studies in genetically modified mice, National Institutes of Environmental Health Sciences announces in July 10 Federal Register 1notice. The meeting will begin at 8:30 a.m. at NIEHS in Research Triangle Park, N.C. Technical reports slated for review include document on benzene, which is used in the manufacture of dyes, oils, varnishes and lacquers. Subcommittee most recently met June 12 to review four technical reports on four other ingredients (2"The Rose Sheet" March 13, 2006, In Brief)...
You may also be interested in...
NTP peer review
National Toxicology Program Board of Scientific Counselors Technical Reports Review Subcommittee will hold a meeting June 12 in Triangle Park, N.C. to review findings and conclusions from four draft NTP Technical Reports on rodent toxicology and carcinogenicity studies conducted by NTP, National Institute of Environmental Health Sciences announces in March 9 Federal Register 1notice. Technical reports include document on methylene blue trihydrate, a dye previously used in hair colorants, as well as a report on alpha-methylstyrene, used in the production of resins and polymers. Subcommittee deliberations will be reported to the NTP Board at a future date...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.